- Home
- TPH vs IOVA Comparison
TPH vs IOVA Comparison
Compare TPH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- IOVA
- Stock Information
- Founded
- TPH 2009
- IOVA 2007
- Country
- TPH United States
- IOVA United States
- Employees
- TPH N/A
- IOVA N/A
- Industry
- TPH Homebuilding
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TPH Consumer Discretionary
- IOVA Health Care
- Exchange
- TPH Nasdaq
- IOVA Nasdaq
- Market Cap
- TPH 4.0B
- IOVA 3.6B
- IPO Year
- TPH N/A
- IOVA N/A
- Fundamental
- Price
- TPH $42.13
- IOVA $10.01
- Analyst Decision
- TPH Buy
- IOVA Strong Buy
- Analyst Count
- TPH 4
- IOVA 10
- Target Price
- TPH $48.00
- IOVA $24.80
- AVG Volume (30 Days)
- TPH 683.7K
- IOVA 7.0M
- Earning Date
- TPH 10-24-2024
- IOVA 11-05-2024
- Dividend Yield
- TPH N/A
- IOVA N/A
- EPS Growth
- TPH N/A
- IOVA N/A
- EPS
- TPH 4.40
- IOVA N/A
- Revenue
- TPH $4,192,540,000.00
- IOVA $32,772,000.00
- Revenue This Year
- TPH $19.13
- IOVA $13,836.92
- Revenue Next Year
- TPH $4.04
- IOVA $183.20
- P/E Ratio
- TPH $9.58
- IOVA N/A
- Revenue Growth
- TPH N/A
- IOVA 13669.75
- 52 Week Low
- TPH $24.18
- IOVA $3.21
- 52 Week High
- TPH $47.78
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- TPH 45.47
- IOVA 46.05
- Support Level
- TPH $42.10
- IOVA $10.32
- Resistance Level
- TPH $44.70
- IOVA $11.80
- Average True Range (ATR)
- TPH 1.13
- IOVA 0.60
- MACD
- TPH -0.21
- IOVA -0.22
- Stochastic Oscillator
- TPH 14.97
- IOVA 11.86
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.